JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 12, 2006; DOI: 10.1124/jpet.106.107433


0022-3565/07/3201-133-144$20.00
JPET 320:133-144, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.107433v1
320/1/133    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balakrishnan, A.
Right arrow Articles by Polli, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balakrishnan, A.
Right arrow Articles by Polli, J. E.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Bias in Estimation of Transporter Kinetic Parameters from Overexpression Systems: Interplay of Transporter Expression Level and Substrate Affinity

Anand Balakrishnan1, Naissan Hussainzada, Pablo Gonzalez, Marival Bermejo, Peter W. Swaan, and James E. Polli

Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland (A.B., N.H., P.G., P.W.S., J.E.P.); and Department of Pharmacy and Technology, University of Valencia, Valencia, Spain (M.B.)

The objective was to investigate the interplay between transporter expression levels and substrate affinity in controlling the influence of aqueous boundary layer (ABL) resistance on transporter kinetics in an over-expression system. Taurocholate flux was measured across human apical sodium-dependent bile acid transporter (hASBT)-Madin-Darby canine kidney monolayers on different occasions and kinetic parameters estimated with and without considering ABL. In error-free simulation/regression studies, flux values were generated across a range of Jmax, Kt, and substrate concentrations. Similar evaluation was performed for transport inhibition studies. Additionally, simulation/regression studies were performed, incorporating 15% random error to estimate the probability of successfully estimating Kt. Across different occasions, experimental Jmax and Kt estimates for taurocholate were strongly associated (p < 0.001; r2 = 0.82) when ABL was not considered. Simulation/regression results indicate that not considering ABL caused this association, such that Kt estimates were highly positively biased at high hASBT expression. In reanalyzing taurocholate flux data using the ABL-present model, Kt was relatively constant across occasions (~5 µM) and not associated with Jmax (p = 0.24; r2 = 0.13). Simulations suggest that Jmax and Kt collectively determined ABL influence, which is most prominent under conditions of low monolayer resistance. Additionally, not considering ABL lead to negatively biased Ki estimates, especially at high Jmax. Error-inclusive simulation/regression studies indicated that the probability of successfully estimating Kt depended on the contribution of ABL resistance to flux; when flux became increasingly ABL-limited, probability of success decreased. Results indicate that ABL resistance can bias Kt and Ki estimates from overexpression systems, where the extent of bias is determined by transporter expression level and substrate affinity.


Received for publication May 5, 2006
Accepted October 11, 2006.

Address correspondence to: Dr. James E. Polli, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn St., HSF2 Rm 623, Baltimore, MD 21201. E-mail: jpolli{at}rx.umaryland.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Gonzalez and J. E. Polli
Impact of Impurity on Kinetic Estimates from Transport and Inhibition Studies
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 296 - 305.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Korjamo, H. Kemilainen, A. T. Heikkinen, and J. Monkkonen
Decrease in Intracellular Concentration Causes the Shift in Km Value of Efflux Pump Substrates
Drug Metab. Dispos., September 1, 2007; 35(9): 1574 - 1579.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.